Entry Point Capital, LLC Care Dx, Inc. Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
A detailed history of Entry Point Capital, LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 3,527 shares of CDNA stock, worth $101,824. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,527Holding current value
$101,824% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding CDNA
# of Institutions
157Shares Held
53.5MCall Options Held
60.8KPut Options Held
34.9K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.7MShares$165 Million0.81% of portfolio
-
Black Rock Inc. New York, NY5.29MShares$153 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.38MShares$126 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.91MShares$113 Million1.02% of portfolio
-
Nikko Asset Management Americas, Inc.2.58MShares$74.4 Million0.47% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.54B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...